This site is intended for healthcare professionals only
LoginRegister
Cipla Appoints New SMPs as Umang Vohra Steps DownCipla Appoints New SMPs as Umang Vohra Steps Down
BiogenBiogen Wins USFDA Nod for Higher-Dose Spinraza Amid Rising SMA Therapy Competition
Wockhardt Gets 5-Year NPPA Price Control Exemption for Nafithromycin 400 mg TabletsWockhardt Gets 5-Year NPPA Price Control Exemption for Nafithromycin 400 mg Tablets
Aarti Pharmalabs Gets Single Observation in USFDA Inspection at Tarapur UnitAarti Pharmalabs Gets 1 Observation in USFDA Inspection at Tarapur Unit
Lupin Gets USFDA Tentative Nod for Generic Pitolisant Tablets for Sleep DisorderLupin Gets USFDA Tentative Nod for Generic Pitolisant Tablets for Sleep Disorder
Centre Engaging States to Promote Generic Drugs: MoS HealthCentre Engaging States to Promote Generic Drugs: MoS Health
Eli Lilly to Ink USD 2 Billion AI Drug Deal with Insilico for GLP-1 Diabetes TherapyEli Lilly to Ink USD 2 Billion AI Drug Deal with Insilico for GLP-1 Diabetes Therapy
Drug Prices Set to Rise as NPPA Clears WPI-Linked Hike for 2025Drug Prices Set to Rise as NPPA Clears WPI-Linked Hike for 2025
GSK Pharma Slapped Rs 23.21 Crore Tax Demand, Plans AppealGSK Pharma Slapped Rs 23.21 Crore Tax Demand, Plans Appeal
Govt Bars Medical Representatives from Central Hospitals to Curb Unethical Pharma MarketingGovt Bars Medical Representatives from Central Hospitals to Curb Unethical Pharma Marketing
Sun Pharma to Present ILUMYA, LEQSELVI, WINLEVI Data at AAD 2026, Showcases Dermatology AdvancesSun Pharma to Present ILUMYA, LEQSELVI, WINLEVI Data at AAD 2026, Showcases Dermatology Advances
Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector VersionSanofi's Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version
X